Redeye Feed

2026-04-13 17:36:00 Herantis Pharma: CEO Antti Vuolanto is interviewed by Redeye’s analyst

2026-04-10 12:20:00 ExpreS2ion Biotech: New patent application in Hong Kong

2026-04-10 11:42:00 Faron Pharmaceuticals: Final outcome of EUR40m rights issue

2026-04-08 08:59:00 Physitrack (Q1 Preview): Focus on margin resilience and growth inflection

2026-04-08 08:57:00 Addnode (Q1 Preview): Solid contribution from M&A, FX hurting – market conditions in focus

2026-04-07 17:41:00 Lime (Q1 Preview): Attractive long-term case, slight cut to Q1 margins

2026-04-07 08:54:00 CombinedX: Value-creating divestment

2026-04-07 08:53:00 FluoGuide: Shining light on a mispriced opportunity

2026-03-25 16:45:00 Alzinova (Q4 Review): Extended runway, still focus on deal

2026-03-25 12:48:00 ExpreS2ion Biotech: Positive interim data, advancing to higher dose

2026-03-24 15:05:00 Faron Pharmaceuticals (Interview): Funded beyond inflection points

2026-03-23 15:33:00 Waystream: SEK3m order from Telia Sweden

2026-03-23 15:32:00 Biovica (Q3 Review): Execution key as revenue drivers emerge

2026-03-23 12:06:00 Redeye initiates coverage of Collaxio

2026-03-16 16:25:00 Xplora has agreed key terms to acquire Emporia Mobile — consolidating senior mobile leadership

2026-03-16 16:24:00 SciBase (Q4 Review): Strong growth, key catalysts ahead

2026-03-13 13:29:00 Bio-Works (Intervju): Verksamhetsuppdatering

2026-03-11 11:10:00 Faron Pharmaceuticals: Final terms of EUR40m rights issue

2026-03-11 11:05:00 Physitrack (Interview): Paving the way to accelerate growth in 2026

2026-03-11 11:02:00 Waystream: New Finnish operator

2026-03-09 12:24:00 Binero Group (H2 2025 Review): Growth and Margin Expansion Expected in 2026

2026-03-06 08:53:00 Lime: CMD strengthens our positive view

2026-03-06 08:52:00 Systemair (Q3 Review): Airpocket in Q3

2026-03-06 08:50:00 GomSpace (Q4 Review): Outlook Solid; Valuation Lifted

2026-03-05 10:56:00 Egetis Therapeutics (Q4 review): US approval on the horizon

2026-03-05 10:55:00 Faron Pharmaceuticals (H2 review): Revised development plan

2026-03-05 10:54:00 Heliospectra (Q4 Review): Positioning for the 2026 market rebound

2026-03-04 10:59:00 NextCell Pharma (year-end report review): Making progress

2026-03-03 16:25:00 SynAct Pharma: Interview about the directed share issue

2026-03-03 16:23:00 SynAct Pharma: Cash Position Further Strengthened

2026-03-03 16:16:00 AAC Clyde Space (Q4 Review): Operational Progress

2026-03-03 10:49:00 AlzeCure Pharma (Q4 2025): Focused execution across core development programmes

2026-03-03 10:47:00 Saniona (Q4 review): Moving forward nicely

2026-03-03 10:46:00 Physitrack (Q4 Review): Strategic reset complete; pivot to pure-SaaS growth acceleration

2026-03-02 12:37:00 Hexatronic: German connectivity and defence exposure for Harsh Environment

2026-03-02 12:35:00 MindArk (Q4 Review): Soft quarter, but outlook largely intact

2026-03-02 11:22:00 OXE Marine (Q4 Review): US Government market on temporary pause

2026-03-02 11:20:00 Xplora (Q4 Review): Doro Connect enters its real channels in 2026

2026-03-02 11:19:00 Paxman (Q4 Review): Quarter below expectations, but IBBM development is encouraging

2026-02-27 14:30:00 Guldbrev (Q4 Review): Gold Momentum Continues

2026-02-27 14:29:00 IRLAB (Q4 Review): IRL757 study on track

2026-02-27 14:28:00 IDL Diagnostics (Q4 Review): Aims to broaden the sales model

2026-02-27 14:27:00 Better Collective (Q4 Review): Solid guidance confirms return to organic growth

2026-02-27 14:26:00 AcouSort (Q4 review): Eventful year ahead

2026-02-27 14:25:00 BioInvent (Q4 Update): Ovarian a New Value Driver

2026-02-27 14:24:00 Sivers Semiconductors (Q4 Review): Positioned for a 2026 Inflection

2026-02-26 15:29:00 OncoZenge (Q4 review): Final preparations ahead of phase III

2026-02-26 11:24:00 Better Collective (Q4 Initial take): Solid Q4 and guidance in line with expectations

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Vem äger bolaget?

Redeye

Prenumeration

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden